doxylamine succinate; pyridoxine hydrochloride
DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE (doxylamine succinate; pyridoxine hydrochloride) by Teva is 12. Approved for nausea, vomiting of pregnancy in women. First approved in 2022.
Drug data last refreshed Yesterday
12.1 Mechanism of Action The mechanism of action of doxylamine succinate and pyridoxine hydrochloride is unknown. 12.3 Pharmacokinetics The pharmacokinetics of doxylamine succinate and pyridoxine hydrochloride has been characterized in healthy non-pregnant adult women. Pharmacokinetic results for…
Worked on DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.